Guillermo Crespo

1.8k total citations
33 papers, 1.0k citations indexed

About

Guillermo Crespo is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guillermo Crespo has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Epidemiology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guillermo Crespo's work include Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (12 papers) and Neuroblastoma Research and Treatments (8 papers). Guillermo Crespo is often cited by papers focused on Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (12 papers) and Neuroblastoma Research and Treatments (8 papers). Guillermo Crespo collaborates with scholars based in Spain, United States and Italy. Guillermo Crespo's co-authors include Jorge Barriuso, Anja Rinke, Ingrid Holst Olsen, Dermot O’Toole, Thomas Walter, Ivan Borbath, C. Chougnet, Selva L. Luna, Carlos Ortega-González and Gabriel Arteaga‐Troncoso and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Cardiology.

In The Last Decade

Guillermo Crespo

29 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guillermo Crespo Spain	14	709	526	362	139	137	33	1.0k
Bonnie J. Trochanowski United States	4	582 0.8×	331 0.6×	209 0.6×	175 1.3×	29 0.2×	5	759
Venessa Tsang Australia	21	600 0.8×	322 0.6×	130 0.4×	211 1.5×	11 0.1×	48	1.1k
Jennifer K. Lowney United States	12	285 0.4×	134 0.3×	65 0.2×	64 0.5×	48 0.4×	14	701
Leena‐Maija Soveri Finland	8	929 1.3×	716 1.4×	492 1.4×	90 0.6×	8 0.1×	13	1.1k
Tom Kurzawinski United Kingdom	16	382 0.5×	243 0.5×	113 0.3×	131 0.9×	11 0.1×	42	891
Piero Ferollà Italy	20	1.3k 1.9×	1.5k 2.8×	963 2.7×	88 0.6×	9 0.1×	42	1.8k
Kae Kawachi Japan	14	186 0.3×	105 0.2×	60 0.2×	99 0.7×	20 0.1×	48	542
Riley Fadden United States	8	714 1.0×	237 0.5×	191 0.5×	77 0.6×	6 0.0×	19	918
Andreas Raffel Germany	19	728 1.0×	789 1.5×	456 1.3×	177 1.3×	5 0.0×	62	1.4k

Countries citing papers authored by Guillermo Crespo

Since Specialization

Citations

This map shows the geographic impact of Guillermo Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Crespo more than expected).

Fields of papers citing papers by Guillermo Crespo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Crespo. The network helps show where Guillermo Crespo may publish in the future.

Co-authorship network of co-authors of Guillermo Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Crespo. A scholar is included among the top collaborators of Guillermo Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Crespo. Guillermo Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Juan-Fita, María José, Urbano Anido Herranz, Carlos Álvarez-Fernández, et al.. (2024). SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain.. Journal of Clinical Oncology. 42(16_suppl). e16561–e16561. 1 indexed citations

Berciano‐Guerrero, Miguel‐Ángel, Ainara Soria, Guillermo Crespo, et al.. (2023). 1174P Sex differences in advanced melanoma in Spain: Results from the prospective real-world study GEM 1801. Annals of Oncology. 34. S697–S698.

Márquez‐Rodas, Iván, Miguel‐Ángel Berciano‐Guerrero, Ainara Soria, et al.. (2022). 848P Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801. Annals of Oncology. 33. S937–S938. 1 indexed citations

Ochenduszko, Sebastián, Guillermo Crespo, Juana Oramás, et al.. (2021). Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. OncoTargets and Therapy. Volume 14. 5345–5352. 5 indexed citations

Benavent, Marta, Javier Sastre, Ignacio Escobar, et al.. (2021). Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS). Health and Quality of Life Outcomes. 19(1). 38–38.

García‐Carbonero, Rocio, Marta Benavent, Daniel Castellano, et al.. (2021). 1097O The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs. Annals of Oncology. 32. S907–S908. 11 indexed citations

Esteban, Emilio, Francisco Expósito, Guillermo Crespo, et al.. (2021). Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers. 13(11). 2849–2849. 13 indexed citations

Capdevila, Jaume, Àlex Teulé, Carlos López, et al.. (2020). 1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601). Annals of Oncology. 31. S770–S771. 37 indexed citations

Salvia, Anna La, Jaume Capdevila, Marta Benavent, et al.. (2020). 1159MO Survival and prognostic factors analysis of 535 grade 3 gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN): Data from the Spanish Taskforce of Neuroendocrine Tumours Registry (R-GETNE). Annals of Oncology. 31. S772–S772. 1 indexed citations

10.

Sanmamed, Miguel F., Emilio Esteban, Ruth Zárate, et al.. (2017). Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours. Journal of Translational Medicine. 15(1). 62–62. 6 indexed citations

11.

Jiménez‐Fonseca, Paula, Alberto Carmona‐Bayonas, Elena Martín‐Pérez, et al.. (2015). Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer and Metastasis Reviews. 34(3). 381–400. 45 indexed citations

12.

Capdevila, Jaume, Isabel Sevilla, Vicente Alonso, et al.. (2015). Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis. BMC Cancer. 15(1). 495–495. 18 indexed citations

13.

Chougnet, C., Ingrid Holst Olsen, Anja Rinke, et al.. (2015). Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocrine Related Cancer. 22(4). 657–664. 277 indexed citations

14.

Walenkamp, Annemiek, Guillermo Crespo, Reidar Fossmark, et al.. (2014). Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment. Endocrine Related Cancer. 21(6). R445–R460. 40 indexed citations

15.

Crespo, Guillermo, Marta Sierra, N. Villanueva, et al.. (2011). Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer. International Journal of Gynecological Cancer. 21(3). 478–485. 8 indexed citations

16.

Galván, José A., et al.. (2010). Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors. Lung Cancer. 69(3). 289–295. 15 indexed citations

17.

Fonseca, Paula Jiménez, Emilio Esteban, M. Luque, et al.. (2008). Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy. Clinical & Translational Oncology. 10(7). 426–432. 3 indexed citations

18.

Maraj, Suraj, et al.. (2003). Undefined Hypercoaguable State Associated With Massive Right Ventricular Thrombus and Embolism in a Previously Healthy 17‐Year‐Old Male. Echocardiography. 20(5). 439–442. 4 indexed citations

19.

Crespo, Guillermo, Larry E. Jacobs, Suraj Maraj, et al.. (2003). Penetrating aortic atherosclerotic ulcer complicated by periesophageal hematoma. Journal of the American Society of Echocardiography. 16(2). 182–184. 3 indexed citations

20.

Wongpraparut, Nattawut, et al.. (2002). Determinants of progression of aortic stenosis in patients aged ≥40 years. The American Journal of Cardiology. 89(3). 350–352. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact